Susan G Komen  
I've Been Diagnosed With Breast Cancer Someone I Know Was Diagnosed Share Your Story Join Us And Stay Informed Donate To End Breast Cancer
    Home > Research & Grants > Grants Program > Research Grants > Research Grants Awarded

    Research Grants Awarded

    2003-2004 Grant Cycle : Research Grants Awarded

    Biology of Breast Cancer

    Understanding Telomere Dynamics in Breast Cancer
    Steven Artandi, MD
    Sripriya Rajaraman
    Stanford University

    $135,000


    Using Mouse Models to Define the Pathway of P53-Mediated Tumor Suppression in Breast Cancer
    Laura Attardi, PhD
    Shashwati Basak
    Stanford University

    $135,000


    INT6 is a Potential Breast Tumor Suppressor Gene that Regulates the Proteasome
    Eric Chang, PhD
    Jinfeng Suo
    Baylor College of Medicine

    $135,000


    Role of Jun Activation Domain-Binding Protein (JAB1) in Breast Tumorigenesis
    Francois Claret, PhD
    Anita Korapati
    The University of Texas MD Anderson Cancer Center

    $135,000


    Wrch1: A Novel Rho GTPase in Breast Cancer Development
    Channing Der, PhD
    Paul Campbell
    University of North Carolina at Chapel Hill

    $135,000


    A Novel Strategy for the Identification of Tumor Suppressors in Human Breast Cancer
    Stephen Elledge, PhD
    Thomas Westbrook
    Harvard Partners Center for Genetics and Genomics

    $135,000


    Regulation of PEA-15 During Breast Cancer Oncogenesis
    Brunhilde Felding-Habermann, PhD
    Joseph Krueger
    The Scripps Research Institute

    $135,000


    The Role of BRCA1 in Development and Maintenance of Genomic Integrity in the Terminal End Bud
    Priscilla Furth, MD
    Shahin Assefnia
    Georgetown University, Lombardi Cancer Center

    $135,000


    Characterization of Mcs7, an Inherited Mammary Carcinoma Susceptibility Locus on Rat Chromosome 10
    Michael Gould, PhD
    Michelle Cotroneo
    University of Wisconsin-Madison

    $135,000


    Functional and Structural Interactions Between Rad51, Rad54, and Brca2 Proteins During Recombinational DNA Repair of DNA Double-Stranded Breaks
    Wolf-Dietrich Heyer, PhD
    Xiao-Ping Zhang
    University of California, Davis

    $135,000


    Molecular Mechanisms of Fas-Mediated Cell Death Induced by Tumor-Specific Ether Lysophospholipid Derivatives.
    Anne-Odile Hueber, PhD
    Krittalak Chakrabandhu
    Institute of Signaling, Developmental Biology, and Cancer

    $135,000


    Molecular Mechanisms of LRH-1 Function in Breast Tissue
    Holly Ingraham, PhD
    Miyuki Suzawa
    University of California, San Francisco

    $135,000


    DNA Methylation of SLIT-2 as a New Marker for the Early Diagnosis and the Use of Soluble SLIT-2 as a New Therapeutic for Breast Cancer
    John Minna, MD
    Catherine Morrissey
    UT Southwestern Medical Center

    $135,000


    The Proteome of Delta Protein Kinase C in Breast Cancer
    Daria Mochly-Rosen, PhD
    Tomoyoshi Koyanagi
    Stanford University School of Medicine

    $135,000


    Role of Gab2 in Breast Cancer
    Benjamin Neel, PhD
    Richard Chan
    Beth Israel Deaconess Medical Center, Harvard Medical School

    $135,000


    E2F Transcription Factors in Mammary Gland Development and Tumorigenesis
    Joseph Nevins, PhD
    Eran Andrechek
    Duke University

    $135,000


    Regulation of Genomic Stability Through Cell Cycle Checkpoint Signaling
    Matthew O'Connell, PhD
    Ana Kosoy
    Mount Sinai School of Medicine

    $135,000


    Defining the Role of a Novel CDK-Related Kinase in Cell Cycle Progression
    Patrick O'Farrell, PhD
    Gilles Hickson
    University of California, San Francisco

    $135,000


    Centrosome Replication and the Role of BRCA1 in Breast Cancer
    Jeffrey Parvin, MD
    Satish Sankaran
    Brigham and Women's Hospital

    $135,000


    THE ROLE OF CXCL12 AND CXCL14 CHEMOKINES IN THE REGULATION OF BREAST CANCER CELL GROWTH AND INVASION
    Kornelia Polyak, MD
    Kandilci Ayten
    Dana-Farber Cancer Institute

    $135,000


    The Role of CKS Proteins in Cell Cycle Control and Breast Cancer
    Steven Reed, PhD
    Li-Chiou Chuang
    The Scripps Research Institute

    $135,000


    Role of Novel Sulfatases in Breast Cancer
    Steven Rosen, PhD
    Roman Nawroth
    University of California San Francisco

    $135,000


    Mechanism for BRCA1 Regulation of Genomic Stability
    Eliot Rosen, MD
    Jeong Rih
    Georgetown University

    $135,000


    Characterization and Targeting of Cell Surface Expressed Nucleolin in Breast Cancer Angiogenesis
    Erkki Ruoslahti, MD
    Valentina Fogal
    The Burnham Institute

    $135,000


    Functional Significance of HtrA1 Downregulation in Breast Cancer: Implications for Platinum Resistance
    Viji Shridhar, PhD
    Jonathan Baines
    The Mayo Clinic/Foundation

    $135,000


    The Role of Estrogen Receptor Coactivators in Tamoxifen Resistance
    Carolyn Smith, PhD
    Eleni Maniatis
    Baylor College of Medicine

    $135,000


    Functional Roles of HOXB7 in Tumorigenesis and Metastasis of Mammary Carcinoma
    Saraswati Sukumar, PhD
    TAO ZHU
    Johns Hopkins University School of Medicine

    $135,000


    Riboflavin Trafficking in Breast Cancer
    Peter Swaan, PhD
    Alan Myers
    University of Maryland

    $135,000


    The Role of TP53 Mutation in Genome Stability and Chemotherapeutic Resistance in Breast Cancer
    Barbara Weber, MD
    Mackenzie De Vos
    University of Pennsylvania

    $135,000


    Vitamin D3 and Wnt/B-catenin Signaling in Mammary Cells
    JoEllen Welsh, PhD
    Matthew Rowling
    University of Notre Dame

    $135,000


    Characterization of the Tumor Suppresssor RASSF1A in Breast Cancer Initiation and Progression
    Michael White, PhD
    Yu-Chen Chien
    University of Texas Southwestern Medical Center at Dallas

    $134,703


    Early Detections, Diagnosis, and Prognosis

    ErbB receptors and resistance to aromatase inhibitors in breast cancer
    Carlos Arteaga, MD
    Tracy Criswell
    Vanderbilt University Medical Center

    $135,000


    Measurement of the X-Ray Attenuation Coefficients of Breast Tissues and Tumors Using Digital Tomosynthesis
    Daniel Kopans, MD
    Tao Wu
    Massachusetts General Hospital

    $135,000


    Etiology

    Molecular Epidemiology of Secondary Lung Cancer in Breast Cancer Patients
    Peter Shields, MD
    Funda Orkunoglu-Suer
    Georgetown University

    $135,000


    Treatment

    Mechanisms of Responses of Cancer Cells to Mutant-Template Telomerase RNA.
    Elizabeth Blackburn, PhD
    Claire Warner
    The Regents of the University of California

    $135,000


    Use of Hypoxia- and Radiation-activated Cre/loxP Switch Vectors for Gene Therapy of Breast Cancer
    Michael Joiner, PhD
    Olga Greco
    Wayne State University

    $135,000


    Mechanistic Synergy of HDAC and Topo II Inhibitors
    Pamela Munster, MD
    Douglas Marchion
    H. Lee Moffitt Cancer Center and Research Institute

    $135,000


    NB2 a Novel Antitumor Agent for Breast Cancer: Implication of Proteomics in Target Identification
    Nouri Neamati, PhD
    Jinxia (Nancy) Deng
    University of Southern California

    $135,000


    The Role of Growth Factors/Stress Signaling Pathways in Developing Endocrine Resistance of Breast Cancer
    Kent Osborne, MD
    Grazia Arpino
    Breast Center, Baylor College of Medicine

    $135,000


    Structure-Based Inhibitor Design for a Cancer Target in De Novo Purine Biosynthesis Pathway
    Ian Wilson, PhD
    Stephen Connelly
    The Scripps Research Institute

    $135,000



    * Pending executed agreement